MIG - Press Review

Technologies of the Future

ARD reports about biotechnology in Germany with a statement of Michael Motschmann, General Partner MIG AG.

Mehr erfahren

Angela Merkel rejects US move to waive patents on vaccines

Among others „Financial Times“ and „DIE WELT“ report about the discussion to waive patents on Covid-19 vaccines, including quotes of Dr. Matthias Kromayer, General Partner MIG AG.

Find out more

Find out more

„Politics should create incentives“

Interview with Michael Motschmann, General Partner MIG AG, in „Abendzeitung“ about the future of German Biotech.

Biotech expects

German News Agency "dpa" reports about the Biotech Business in Germany with quotes of Michael Motschmann, General Partner MIG AG. Around 150 media published the article of dpa, among them ...

Mehr erfahren

Quantum Computing – it starts to be serious

A podcast of „Manager Magazin“ explains the state of the art of Quantum Computing and mentions MIG portfolio company IQM as a leading player and Michael Motschmann, General Partner MIG AG, as investor.

Find out more

Super Quanten

„Süddeutsche Zeitung“ reports about an innovative Quantum Computing Project of Leibnitz Rechenzentrum (LRZ) in Garching/Munich integrating IQM, a MIG portfolio company.

Find out more

Going viral

In an article about the German Biotech Industry „Manager Magazin“ quotes Dr. Matthias Kromayer, General Partner of MIG AG.

Six Start-ups are the German Hope in Quantum Computing

„Handelsblatt“ mentions IQM, a MIG portfolio company, as one of the leading German start-ups in Quantum Computing

Find out more

The next enemy will be tougher

„Wirtschaftswoche“ explains the future of MIG portfolio company BioNTech with quotes of Michael Motschmann, General Partner MIG AG.

Find out more

The dark of COVID-19 brings promise to Germany´s biotech scene

Trade publication „BioCentury“ quotes Michael Motschmann, General Partner of MIG AG, in an article about the future of German Biotech industry.

Find out more

Next MIG Invest in Medical Technology

Several Trade Magazines report about MIGs investment in new portfolio company Creative Balloons.

Find out more

Find out more

Record return for MIG because of Biontech

„Börsen Zeitung“ interviews Michael Motschmann, General Partner of MIG AG, about new developments at MIG

BioNTech Fund (MIG) pays 600m Euro dividend on back of vaccine success

International and national media among them „Financial Times“ and „Reuters“ report about the record payment of MIG Fonds of 600m Euro to investors.

Find out more

Find out more

Find out more

Find out more

Find out more

Exosceletts reduce sick days

„Handelsblatt“ reports about the technology of GBS, a start-up producing exosceletts; MIG Fonds invested recently.

Find out more

Express

„Süddeutsche Zeitung“ describes how BioNTech developed in a very short period the vaccine against Covid-19 and marks Michael Motschmann, General Partner of MIG AG, as one of the first investors of BioNTech.

Find out more

German Bionic raises $20 M led by Samsung for exoskeleton tech to supercharge human labor

„Techcrunch“ and other media report about a Series A-Financing of German Bionic Systems by MIG Fonds and other investors.

Find out more

Find out more

The couple behind the vaccine against Covid-19

„Tagesschau.de“ portrays Özlem Türeci and Ugur Sahin, the founder of MIG-portfolio company BioNTech, and quotes Michael Motschmann, General Partner of MIG AG.

Find out more

Start-up Konux gets a large order from Deutsche Bahn

„Handelsblatt“ reports about a large order of Deutsche Bahn to Konux, a MIG Portfolio company.

Find out more

Great Britain approves vaccine of Biontech and Pfizer against Covid 19

Like other media around the globe „FAZ“ reports about the first approval of Biontechs vaccine against Covid-19.

Find out more

Application for admission of Corona vaccine submitted

„DIE ZEIT“ reports like many other media around the globe that MIG portfolio company BioNTech together with Pfizer submitted the application for admission of their Covid-19 vaccine at FDA .

Find out more

„Never in my career I met such a brilliant couple“

Michael Motschmann, General Partner of MIG AG, and Thomas Strüngmann explain in an interview with „Süddeutsche Zeitung“ their relationship as investors to BioNTech founders Prof. Dr. Ugur Sahin and Özlem Türeci.

Find out more

IQM Hope in Quantum Computing

German business newspaper „Handelsblatt“ portrays MIG portfolio company IQM in a comprehensive article as hope of the European Quantum Computing Industry.

Find out more

MIG Fonds lead financing round at IQM

Several media report a 36 Mio. Euro financing round at IQM Quantum Computing led by MIG Fonds.

Find out more

Find out more

Find out more

Find out more

Behind Pfizer´s vaccine, an understated husband-and-wife „dream team"

Newswire „Reuters“ is portraying the couple behind BioNTech with quotes of Dr. Matthias Kromayer, General Partner MIG AG and for many years member of the supervisory board of BioNTech.

Find out more

If the digital consultant cares about your finance

reports about digital platforms in the finance industry and mentions wealthpilot, a MIG portfolio company.

Find out more

We get close to the target

Prof. Dr. Ugur Sahin, CEO of MIG portfolio company BioNTech, explains in an interview with „FAS“ the state of the art of the development of a vaccine against Covid-19.

Golden Rain at Nasdaq

Quote of Dr. Matthias Kromayer in an article of „Börse Online“ about IPOs of Biontech companies at Nasdaq.

How a Start-up tries to avoid deadly infections in clinics

In a portray of MIG portfolio company GWA Hygiene GmbH newspaper „Frankfurter Rundschau“ explains the business model of the firm.

Find out more

The new Spirit of equal Opportunities

German Newspaper „DIE WELT“ portrays Gloria Seibert, founder of MIG portfolio company Temedica.

Find out more

Enormous demand

„Handelsblatt“ decribes the market for vaccines against Covid 19. The potential revenues in the first phase could be around 20 Billion US Dollar for firms like BioNTech, a portfolio company of MIG Fonds.

Find out more

Biontech Vaccine: Good data creat hope in turnaround

„Focus“ and other media report about good results of BioNTech, a MIG portfolio company, in search of a vaccine against Covid-19.

Find out more

„It´s not a question to participate in a race“

„Süddeutschen Zeitung“ interviews Prof. Dr. Ugur Sahin, CEO of MIG portfolio company BioNTech, about the state of the art in developing a vaccine against Covid-19.

Find out more

Costs nothing, not destroyable

Magazine „Focus“ reports, how Airbus will beat Boing with new materials from Amsilk, a MIG-portfolio company.

Find out more

Biontech expects first data til July in their development of a vaccine against Covid-19

Several media reports new steps of BioNTech, a MIG portfolio company, in search of a vaccine against the new Coronavirus.

Find out more

First clinical study for a Corona-Vaccine in Germany approved

FAZ and other media report, that in Germany for the first time a clinical study got the approval to test a Corona-Vaccine. MIG-Portfolio company BioNTech is allowed to start tests of his vaccine with volunteers.

Find out more

Find out more

Power-Paar against SARS-CoV-2

„Manager Magazin Online“ portrays Ugur Sahin and Özlem Türeci of BioNTech and acknowledge the role of MIG Fonds in founding and financing the firm.

Find out more

AFFiRiS erhält Patent für Parkinson-Medikament in China

„Going Public“ reports about progresses of MIG portfolio company AFFiRiS. The biotech firm, based in Vienna, got a patent in China and will start a clinical study (Parkinson) in the second half of the year.

Find out more

Immatics is planning a listing on the Nasdaq

Several national and international media are reporting about the IPO-plans of MIG portfolio company Immatics in Q2. on the Nasdaq.

Find out more

Find out more

Find out more

The IPO took BioNTech onto the international stage

„Life Sciences“ is interviewing Sierk Pötting, BioNTech SE, and Michael Motschmann, General Partner der MIG AG, about the success of BioNTech.

Mehr erfahren

Third Investment of MIG 16

Trade magazine „Finanzwelt“ reports about MIG Fonds newest investment in Neracare GmbH.

Find out more

Immatics closes second TCR-T-Billion Deal

Trade Magazine „transkript“ reports about a deal between immatics, a MIG porfolio company, and GlaxoSmithKline, which assures immatics milestone payments up to 1.1 Billion US Dollar.

Find out more

„For me it would not be enough to sell shoes online“

Interview with Gloria Seibert, founder of Temedica, a new MIG portfolio company.

Find out more

Series B Funding of Temedica

Several media report about the 17 million Euro series-B-financing round of Temedica, which was led by MIG Fonds.

Find out more

Find out more

Find out more

The Best Machine Learning Startups to Work For In 2020 Based On Glassdoor

US business magazine „Forbes“ counts KONUX among the 15 best startups to work for in the field of machine learning. KONUX is a MIG portfolio company.

Find out more

Europe has to achieve a leading role in Quantum Computing

Dr. Jan Goetz, CEO of IQM, explains in a by line article in „Handelsblatt.com“, why Europa beside the USA and China should participate in the race for the first scalable Quantum Computer. IQM is a leading European Quantum Computing Start-up and a MIG portfolio company.

Find out more

Biontech-CEO Sahin explains, what the IPO is changing

German business newspaper „Handelsblatt“ honors the significance of the IPO of Biontech, a MIG portfolio company, for the Biotech sector of Germany.

Find out more

Find out more

IPO of BioNTech

Several media report about the IPO of BioNTech at Nasdaq, New York.

Find out more

Find out more

Find out more

FutureCarbon presents a new system of infrared heating

An announcement informs about a new product of FutureCarbon, a MIG portfolio company.

Find out more

Biotech-firm Immatics closes a Billion-Deal with Celgene

Business newspaper „Handelsblatt“ reports about a new cooperation of Immatics. The article names MIG Fonds as a VC-Investor of Immatics.

Find out more

Top-Deal for Start-up of Stralsund

Regional newspaper „Ostsee-Zeitung“ reports about a cooperation between MIG portfolio company GWA Hygiene and big pharma B. Braun Melsungen, which drives internationalization of GWA.

Find out more

MIG Fonds invest in Finnish Start-up

Some national und international media report about the new investment of MIG Fonds in IQM, a Finnish start-up focusing on quanten computing.

Find out more

Find out more

OLED Materials Innovator CYNORA Secures US$25M in First Closing of Series C Round.

„Crunchbase“, „Display Daily“ and other US-Trade Magazines report about a successful 25 Mio. US Dollar Series C Round of CYNORA. MIG Fonds participated in further financing of the portfolio company.

Find out more

Find out more

Givaudan buys Cosmetics of AMSilk

A trade magazine informs about the sale of the cosmetic business of Amsilk, a MIG portfolio company, to the world largest producer of perfume and flavours.

Find out more

In Search for a Biotope

The article describe the landscape of German biotech firms and mention MIG Fonds as an important investor.

MIG Fonds invest in Denmark

Several media report about MIG Fonds newest investment in Danish platform Liva Healthcare.

Find out more

Find out more

Well founded

In a TV-report of „ZDF“ about the European start-up landscape altough NaVvis is mentioned, a MIG portfolio company.

Find out more

The dilemma of success

„DER SPIEGEL“ portrayed over the last years „champions of tomorrow“ and reports now about their development. Among the start-ups are NaVvis and BioNTech, two MIG portfolio companies.

Another Big Pharma invests in German Biotech-Star

Beside other media „Handelsblatt“ reports about a 80 Millionen Euro investment of Sanofi in BioNTech, a MIG portfolio company.

Find out more

NavVis: The Indoor Street View receives 31 Millionen Euro

Several Media reports about a series C financing round of NaVis. MIG Fonds are participating and increase their shares.

Find out more

Find out more

MIG with various IPO-Options

Michael Motschmann, General Partner of MIG AG, explains in „Börsen-Zeitung“ the business modell and perspectives of MIG.

Find out more

Infineon buys technology of the future

Leading newspaper „FAZ“ reports about the acquisition of Siltectra by Infineon and indicates MIG Fonds as main VC investor.

New vaccine as purpose

The newspapers „FAZ“ and „Handelsblatt“ report about a new approach of BioNTech, a MIG-portfolio comany, to develop a new vaccine against infectious diseases partnering with an US-University.

Find out more

Siltectra Ramps Up Wafering Services

Trade Magazin „Compound Semiconductor“ reports about a new outsourcing wafering service of Siltectra, a MIG portfolio company and disruptive innovator in Cold Split wafering.

Find out more

Aircrafts hanging on a silk thread

„Süddeutsche Zeitung“ reports about a cooperation between Airbus Group and Amsilk, a MIG portfolio company, in terms of new materials based on Amsilks technology.

Find out more

High expectations

Business Magazin "Capital" describes the business model and the perspectives of BioNTech, a MIG portfolio company

BioNTech gets Pfizer as partner

„Handelsblatt“, „FAZ“ and „Spiegel Online“ report about a cooperation between Pfizer and BioNTech, a MIG portfolio company.

Find out more

Find out more

Find out more

MIG-Fonds invest in better hospital hygiene

„Finanzwelt“ reports about the new MIG portfolio company GWA Hygiene.

Find out more

MIG with investment in new portfolio company

Die „Finanzwelt“ berichtet über den Einstieg der MIG in ein weiteres Beteiligungsunternehmen.

Find out more

How two start-ups fight against plastic waste

„FAZ“ describes the business models of two start-ups recycling plastic, among them the disruptive approach of APK, a MIG portfolio company.

A new breed of German Start-ups

British „Economist“ describes the booming German start-up scene and focus although on Konux and NavVis, two MIG portfolio companies.

Find out more

The Biontech-Wonder of Mainz

Newsmagazine „Focus“ dedicate a signature article to the development of BioNTech, a MIG portfolio company

Money for new ideas

„Süddeutsche Zeitung“ explains based on case study KEWAZO, a portfolio company of MIG Fonds, how financing of a start-up is working and calls MIG a leading German Venture Capital Investor

Find out more

NFON with a successful IPO

„Wirtschaftswoche“ among several media reports about the successful IPO of NFON, a MIG- portfolio company.

Find out more

Further Investment Konux

Several media report about the participation of MIG Fonds of 5 million US-Dollar in a Series B financing round of Konux, a portfolio company of MIG Fonds.

Find out more

Find out more

NFON is preparing an IPO

Cloud telephony provider NFON announces plans for an IPO. Two MIG Fonds are holding shares of together 13,3 percent of NFON.

Find out more

News about Siltectra

Trade Magazines report, that Siltectra, a portfolio company of MIG Fonds, succeed with a technological breakthrough. The start-up from Dresden splits wafers with it´s so called twinning method and helps to cut costs for manufacturers.

Semiconductor Today: Find out more

Solid State Technology: Find out more

Double success for hunters of metabolites

Trade magazine „Labor Journal“ explains the recent strategic progresses of Biocrates, a portfolio company of MIG Fonds.

Find out more

Konux awarded as one of 30 global „Technology Pioneers“

WEF/Davos has nominated Konux, a portfolio company of MIG Fonds, as one of the most innovative start-ups – beside Google, Dropbox and Twitter.

Find more out

US Investors bet on German Biotech-Unicorn

„Handelsblatt“ reports about fundraising of BioNTech, a portfolio company of MIG Fonds, and explains how the firm will invest the 270 million $.

Find out more

Biocrates takes over Metanomics

Trade magazine „transcript“ reports about the acquisition of Metanomics by Biocrates, a portfolio company of MIG Fonds. BASF Plant Services, the former owner of Metanomics, is now a minor stakeholder of Biocrates.

Find out more

Injection instead of scalpel

„Spiegel Wissen“ explains the state of the art of the research respect to the injection against cancer. In the center of the article is the work of Prof. Dr. Ugur Sahin, CEO of BioNTech, a portfolio company of MIG Fonds.

Disruptive Technology in Display Industry

„Venture Capital Magazin“ reports about the progress of CYNORA, a portfolio company of MIG Fonds. MIG AG Venture Partner Dr. Axel Thierauf explains the perspectives of CYNORA.

Find out more

RAC Cooling Industry Award 2017

Efficient Energy, a portfolio company of MIG Fonds, scooped a well-respected award of the refrigeration technology sector for its innovative generation  eChillern

Find out more

LG und Samsung investieren 25 Millionen Euro in Cynora

An article about LG and Samsung, two Korean global corporations, to share in Cynora 

Find out more

Search for the perfect blue

In its serial „Secret Stars“ of regional economy „BNN“ portrays Cynora, a MIG Fonds portfolio company.

To fight cancer with vaccines

A detailed article of „Frankfurter Allgemeine Zeitung“ about approach and prospects of BioNTech to defeat cancer

Find out more

Each to his own medicine

„Der Spiegel“ with a detailed profile about the previous track record of BioNTech, a portfolio company of MIG Fonds.

Find out more

Spider silk without spiders

„Handelsblatt“ describes in detail on technology and application of AMSilk, MIG Fonds are mentioned as investors

Find out more

Konux receives award “Technology Pioneer 2017”

The respected World Economic Forum (WEF) recently presented a list oft he worlds most innovatiye companies, among them also Konux.

Find out more

We are close to defeat cancer

In an interview with „Frankfurter Allgemeine Sonntagszeitung“ comments Thomas Strüngmann on his investment strategiy and points detailed to BioNTech. Beside the Family Office of the brothers Strüngmann also MIG Fonds are shareholders of this Biotech company.

Clever Track, alert Track Switch

An article of „Handelsblatt“ about how Deutsche Bahn, amongst others suppported by the Start-up Konux, wants to avoid delays and cancellations.

Find out more

Awarded Start-ups

„Handelsblatt“ annually awards the digital prize „The Spark“. As a finalist of previous year Konux, a portfolio company of MIG Fonds, presented its business model.

Find out more

The next exit

Finanzwelt addresses MIG Fonds‘ next exit

Find out more

Targeted Metabolomics

The scientific journal „Laborpraxis“ characterizes in a three-pager the use of Biocrates-kits for detections of individual health status. Biocrates is a portfolio company oft he MIG Fonds.

The data vacuum

In a series of articles on the “Champions of Tomorrow”, der SPIEGEL presents NavVis GmbH, a portfolio company of MIG Fonds.

Top 40 under 40

The economic journal “Capital” runs a cover story on Germany’s young elite featuring Andreas Kunze, CEO of MIG portfolio company Konux.

German biotechnology: foreign companies want in

The Handelsblatt has published an article shedding some light on the sale of MIG portfolio company Ganymed to Japanese pharmaceutical company Astellas. MIG is named as the venture capitalist.

We’re at the beginning of an era

Jürgen Eck, CEO of BRAIN AG, a MIG portfolio company, explains why he believes the trend for natural solutions in the chemical and consumer goods industry will keep on growing and growing.

Millions from California for the biotech pioneers from Mainz

Frankfurter Allgemeine Sonntagszeitung publishes an article about partnership between BioNTech, a MIG portfolio company, and the pharmaceutical company Genentech. Genentech has made an upfront payment of 310 million dollars to BioNTech.

Biontech deal sees Roche bet on mRNA

The article by EP Vantage covers the latest partnership entered into by MIG portfolio company BioNTech aiming to advance developments of mRNA-based cancer vaccines. The pharmaceutical group Roche is also in on the latest deal.

Find out more

Inspiration in instalments

For a case study conducted by Harvard Business Manager, Dr. Matthias Kromayer, member of the Executive Board at MIG AG, discusses three principles of strategic company management.

Playing with your own money “kills your ego”

Profile of the MIG portfolio company Konux and its co-founder Andreas Kunze.

Find out more

First universal cancer vaccine within reach

The article outlines MIG portfolio company BioNTech’s ground-breaking progress in the fight against cancer.

Find out more

Start-up company Konux – the defect detector

Smart sensors and prominent investors: MIG portfolio company Konux wants to revolutionise the untended German industry by helping to eliminate faults before they even occur.

Find out more

China stumps up billions for German entrepreneurs

Heinrich von Pierer describes the latest trend, whereby Chinese sovereign wealth funds are ending up in Germany as venture capitalist funds – a development which can even create opportunities for MIG.

Find out more

One number, a worldwide connection

SZ features an article outlining the wide-reaching scope of the collaboration between Nfon, an MIG portfolio company, and German Telekom in developing cloud-based telephone systems.

Find out more

Indoor satnavs

Handelsblatt has published an extensive profile on NavVis, citing MIG AG as a key VC investor who has been channeling money into the up-and-coming business since 2014.

Technological company Brain goes public

Dr. Heinrich von Pierer has written an article explaining what consequences the IPO of Brain AG, an MIG Fonds portfolio company, will have for the German start-up business scene.

Find out more